Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status

Fig. 7

Combined proteomics and metabolomics pathway network map of significantly altered metabolites and proteins in ERG-positive prostate cancer compared to ERG-negative prostate cancer. Metabolites significantly increased in ERG-positive PC are marked on red, significantly decreased in ERG-positive PC are marked on blue. Significantly altered proteins are presented on box and whisker plots illustrating normalized intensities differences between benign samples (green box), ERG-negative PC (blue box) and ERG-positive PC (red box)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us